DETECTION OF HUMAN CYTOMEGALOVIRUS IN PLASMA OF AIDS PATIENTS DURING ACUTE VISCERAL DISEASE BY DNA AMPLIFICATION

被引:165
作者
SPECTOR, SA [1 ]
MERRILL, R [1 ]
WOLF, D [1 ]
DANKNER, WM [1 ]
机构
[1] UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093
关键词
D O I
10.1128/JCM.30.9.2359-2365.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
By using the polymerase chain reaction (PCR) amplification procedure, 19 (83%) of 23 plasma specimens obtained from individuals with AIDS and human cytomegalovirus (HCMV) visceral disease were found to be positive for plasma viremia as detected by PCR (PV-PCR), whereas 78% of cultures of peripheral blood leukocytes from the same samples were found to be positive. All 11 specimens prospectively obtained from individuals with acute HCMV disease were positive by PV-PCR. Plasma specimens from patients who received ganciclovir therapy rapidly became both culture and PV-PCR negative, and there was an excellent correlation between the two procedures. DNA detected by PV-PCR was unaffected by filtering plasma through a 0.2-mu-m-pore-size filter, although a conserved cellular gene, HLA-DQ-alpha, was undetectable by PCR following filtration. HCMV DNA in plasma could be quantitated by PV-PCR by using endpoint serial dilutions, with detectable virus being present in 10(1) to 10(-2)mu-l of plasma. A low titer of infectious virus could be detected in 2 of 11 plasma samples. The detection of HCMV DNA in plasma by PV-PCR promises to be a useful procedure for monitoring patients with AIDS suspected of having impending, acute, or recurrent HCMV visceral disease and suggests an additional route by which virus may disseminate in the immunocompromised host.
引用
收藏
页码:2359 / 2365
页数:7
相关论文
共 41 条
  • [1] ALFORD C A, 1990, P1981
  • [2] CYTOMEGALOVIRUS (CMV) IN COMPROMISED HOST(S)
    BETTS, RF
    HANSHAW, JB
    [J]. ANNUAL REVIEW OF MEDICINE, 1977, 28 : 103 - 110
  • [3] BUFFONE GJ, 1986, J INFECT DIS, V154, P163, DOI 10.1093/infdis/154.1.163
  • [4] RAPID DETECTION AND QUANTITATION OF HUMAN CYTOMEGALOVIRUS IN URINE THROUGH DNA HYBRIDIZATION
    CHOU, S
    MERIGAN, TC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (16) : 921 - 925
  • [5] LOCALIZATION OF HUMAN CYTOMEGALOVIRUS IN PERIPHERAL-BLOOD LEUKOCYTES BY INSITU HYBRIDIZATION
    DANKNER, WM
    MCCUTCHAN, JA
    RICHMAN, DD
    HIRATA, K
    SPECTOR, SA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01) : 31 - 36
  • [6] DEMMLER GJ, 1988, J INFECT DIS, V158, P177
  • [7] PREVALENCE OF RESISTANCE IN PATIENTS RECEIVING GANCICLOVIR FOR SERIOUS CYTOMEGALOVIRUS-INFECTION
    DREW, WL
    MINER, RC
    BUSCH, DF
    FOLLANSBEE, SE
    GULLETT, J
    MEHALKO, SG
    GORDON, SM
    OWEN, WF
    MATTHEWS, TR
    BUHLES, WC
    DEARMOND, B
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) : 716 - 719
  • [8] PYROPHOSPHATE ANALOGS AS INHIBITORS OF DNA-POLYMERASES OF CYTOMEGALOVIRUS, HERPES-SIMPLEX VIRUS AND CELLULAR-ORIGIN
    ERIKSSON, B
    OBERG, B
    WAHREN, B
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 696 (02) : 115 - 123
  • [9] 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE - A SELECTIVE INHIBITOR OF HERPES GROUP VIRUS-REPLICATION
    FIELD, AK
    DAVIES, ME
    DEWITT, C
    PERRY, HC
    LIOU, R
    GERMERSHAUSEN, J
    KARKAS, JD
    ASHTON, WT
    JOHNSTON, DBR
    TOLMAN, RL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (13): : 4139 - 4143
  • [10] MONITORING OF HUMAN CYTOMEGALOVIRUS INFECTIONS AND GANCICLOVIR TREATMENT IN HEART-TRANSPLANT RECIPIENTS BY DETERMINATION OF VIREMIA, ANTIGENEMIA, AND DNAEMIA
    GERNA, G
    ZIPETO, D
    PAREA, M
    REVELLO, MG
    SILINI, E
    PERCIVALLE, E
    ZAVATTONI, M
    GROSSI, P
    MILANESI, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03) : 488 - 498